3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
Ya’an Kang(The University of Texas MD Anderson Cancer Center), Michael P. Kim(The University of Texas MD Anderson Cancer Center)
Cited by 34
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
|Cancer Discovery|2024|234
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
|Clinical Cancer Research|2018|111
Impact of the <scp>COVID</scp>‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter
|Catheterization and Cardiovascular Interventions|2020|50